Joseph Caprini to Arthroplasty, Replacement, Hip
This is a "connection" page, showing publications Joseph Caprini has written about Arthroplasty, Replacement, Hip.
Connection Strength
1.578
-
A New Chapter Regarding Thrombosis Risk Assessment in Total Joint Replacement Patients. Thromb Haemost. 2024 03; 124(3):236-238.
Score: 0.723
-
Dabigatran etexilate and concomitant use of non-steroidal anti-inflammatory drugs or acetylsalicylic acid in patients undergoing total hip and total knee arthroplasty: no increased risk of bleeding. Thromb Haemost. 2012 Jul; 108(1):183-90.
Score: 0.329
-
Economic burden of long-term complications of deep vein thrombosis after total hip replacement surgery in the United States. Value Health. 2003 Jan-Feb; 6(1):59-74.
Score: 0.172
-
The influence of oral anticoagulation therapy on deep vein thrombosis rates four weeks after total hip replacement. J Vasc Surg. 1999 Nov; 30(5):813-20.
Score: 0.138
-
Dabigatran versus enoxaparin for prevention of venous thromboembolism after hip or knee arthroplasty: a pooled analysis of three trials. Thromb Res. 2010 Sep; 126(3):175-82.
Score: 0.072
-
Efficacy and safety of dabigatran etexilate for the prevention of venous thromboembolism following total hip or knee arthroplasty. A meta-analysis. Thromb Haemost. 2009 Jan; 101(1):77-85.
Score: 0.065
-
Results of an economic model to assess the cost-effectiveness of enoxaparin, a low-molecular-weight heparin, versus warfarin for the prophylaxis of deep vein thrombosis and associated long-term complications in total hip replacement surgery in the United States. Clin Ther. 2002 Nov; 24(11):1960-86; discussion 1938.
Score: 0.043
-
The use of a Bayesian forecasting model in the management of warfarin therapy after total hip arthroplasty. J Arthroplasty. 1999 Dec; 14(8):988-93.
Score: 0.035